Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Feb 22;11(5):1601–1610. doi: 10.3892/etm.2016.3102

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Jia et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 2. — Comparison of the percentages of peripheral lymphocyte subsets and the ratio of CIK/PBMC in the first cycle and second cycle of therapy. (A) CD3⁺CD4⁺ lymphocytes, (B) CD3⁺CD8⁺ lymphocytes and (C) CD3⁺CD56⁺ lymphocytes in the first cycle; (D) CD3⁺CD4⁺ lymphocytes; (E) CD3⁺CD8⁺ lymphocytes and (F) CD3⁺CD56⁺ lymphocytes in the second cycle; CD3⁺ lymphocytes in (G) the first cycle and (H) the second cycle; (I) The ratio of CIK and PBMC in the first cycle (CIK/PBMC-1) and second cycle (CIK/PBMC-1) CIK, cytokine-induced killer; PBMC, peripheral blood mononuclear cell; CD, cluster of differentiation.